EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Psychometric evaluation of the Adelphi Adherence Questionnaire ( ADAQ ©) in a type 2 diabetes mellitus population as a new measure of adherence and the complex factors influencing adherence in routine care

Jan Stochl, Nathan Clarke, Daniel Green iD, Jonathan Comins, Victoria Higgins, James Piercy, Rob Arbuckle, Tariq Halasa, Thaís Rocha, Kamlesh Khunti iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Jan Stochl und 9 weiteren Autor:innen. Beteiligte Einrichtung: Adelphi Values, Bollington, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Medication Adherence. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims To evaluate the psychometric properties of the Adelphi Adherence Questionnaire (ADAQ©) as an adherence measure in a diverse type 2 diabetes mellitus (T2DM) population in routine clinical practice. Materials and Methods Data were drawn from the Adelphi T2DM Disease Specific Programme™, a survey of physicians and adults with T2DM consulting in the United States, February–May 2021. Participants completed the ADAQ and single questions on medication satisfaction and convenience. Latent variable modelling (exploratory/confirmatory factor analyses, item response theory, Mokken scaling and bifactor analyses) assessed ADAQ dimensionality and composite scoring. Differential item functioning (DIF) analyses were conducted between participants taking injectable and non‐injectable therapies, and with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Hypoglycemic AgentsMedication AdherenceHumansMaleFemaleMiddle AgedPsychometricsSurveys and QuestionnairesAgedAdultReproducibility of ResultsPatient SatisfactionUnited States

Stichwörter der Autor:innen

ADAQAdelphi adherence questionnaireMLTCT2DMmultiple long‐term conditionspsychometric evaluation

Substanzen

Hypoglycemic Agents

Autor:innen und Institutionen

  • Adelphi Values, Bollington, UK.
  • Department of Kinanthropology, Charles University, Prague, Czechia.
  • Adelphi Real World, Bollington, UK.
  • Novo Nordisk A/S, Søborg, Denmark.
  • Diabetes Research Centre, University of Leicester, Leicester, UK.

ORCID-Profile: Daniel Green, Kamlesh Khunti

Förderung

  • Novo Nordisk

Zitieren

APA

Stochl, J., Clarke, N., Green, D., Comins, J., Higgins, V., Piercy, J., Arbuckle, R., Halasa, T., Rocha, T., & Khunti, K. (2025). Psychometric evaluation of the Adelphi Adherence Questionnaire ( ADAQ ©) in a type 2 diabetes mellitus population as a new measure of adherence and the complex factors influencing adherence in routine care. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16551

Vancouver

Stochl J, Clarke N, Green D, Comins J, Higgins V, Piercy J, et al. Psychometric evaluation of the Adelphi Adherence Questionnaire ( ADAQ ©) in a type 2 diabetes mellitus population as a new measure of adherence and the complex factors influencing adherence in routine care. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16551

BibTeX
@article{Stochl2025,
  author = {Stochl, Jan and Clarke, Nathan and Green, Daniel and Comins, Jonathan and Higgins, Victoria and Piercy, James and Arbuckle, Rob and Halasa, Tariq and Rocha, Thaís and Khunti, Kamlesh},
  title = {Psychometric evaluation of the Adelphi Adherence Questionnaire ( ADAQ ©) in a type 2 diabetes mellitus population as a new measure of adherence and the complex factors influencing adherence in routine care},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16551}
}
Kostenlos starten →